These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 17605005

  • 1. Neurocognitive function in current and ex-users of ecstasy in comparison to both matched polydrug-using controls and drug-naïve controls.
    Hoshi R, Mullins K, Boundy C, Brignell C, Piccini P, Curran HV.
    Psychopharmacology (Berl); 2007 Oct; 194(3):371-9. PubMed ID: 17605005
    [Abstract] [Full Text] [Related]

  • 2. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
    de Sola Llopis S, Miguelez-Pan M, Peña-Casanova J, Poudevida S, Farré M, Pacifici R, Böhm P, Abanades S, Verdejo García A, Langohr K, Zuccaro P, de la Torre R.
    J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
    [Abstract] [Full Text] [Related]

  • 3. Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?
    Morgan MJ, McFie L, Fleetwood H, Robinson JA.
    Psychopharmacology (Berl); 2002 Jan; 159(3):294-303. PubMed ID: 11862362
    [Abstract] [Full Text] [Related]

  • 4. Impaired cognitive performance in drug free users of recreational ecstasy (MDMA).
    Gouzoulis-Mayfrank E, Daumann J, Tuchtenhagen F, Pelz S, Becker S, Kunert HJ, Fimm B, Sass H.
    J Neurol Neurosurg Psychiatry; 2000 Jun; 68(6):719-25. PubMed ID: 10811694
    [Abstract] [Full Text] [Related]

  • 5. Neuropsychological function in ecstasy users: a study controlling for polydrug use.
    Roiser JP, Rogers RD, Sahakian BJ.
    Psychopharmacology (Berl); 2007 Jan; 189(4):505-16. PubMed ID: 16163532
    [Abstract] [Full Text] [Related]

  • 6. Everyday memory deficits in ecstasy-polydrug users.
    Montgomery C, Fisk JE.
    J Psychopharmacol; 2007 Sep; 21(7):709-17. PubMed ID: 17606476
    [Abstract] [Full Text] [Related]

  • 7. Event related potential (ERP) evidence for selective impairment of verbal recollection in abstinent recreational methylenedioxymethamphetamine ("Ecstasy")/polydrug users.
    Burgess AP, Venables L, Jones H, Edwards R, Parrott AC.
    Psychopharmacology (Berl); 2011 Aug; 216(4):545-56. PubMed ID: 21390504
    [Abstract] [Full Text] [Related]

  • 8. Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug.
    Fox HC, Parrott AC, Turner JJ.
    J Psychopharmacol; 2001 Dec; 15(4):273-81. PubMed ID: 11769821
    [Abstract] [Full Text] [Related]

  • 9. The harmful health effects of recreational ecstasy: a systematic review of observational evidence.
    Rogers G, Elston J, Garside R, Roome C, Taylor R, Younger P, Zawada A, Somerville M.
    Health Technol Assess; 2009 Jan; 13(6):iii-iv, ix-xii, 1-315. PubMed ID: 19195429
    [Abstract] [Full Text] [Related]

  • 10. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R, Zapletalova P, Petersen K, Buchert R, Andresen B, Wartberg L, Nebeling B, Schmoldt A.
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [Abstract] [Full Text] [Related]

  • 11. Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users.
    Fox HC, McLean A, Turner JJ, Parrott AC, Rogers R, Sahakian BJ.
    Psychopharmacology (Berl); 2002 Jul; 162(2):203-14. PubMed ID: 12110998
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Elevated impulsivity and impaired decision-making in abstinent Ecstasy (MDMA) users compared to polydrug and drug-naïve controls.
    Morgan MJ, Impallomeni LC, Pirona A, Rogers RD.
    Neuropsychopharmacology; 2006 Jul; 31(7):1562-73. PubMed ID: 16292322
    [Abstract] [Full Text] [Related]

  • 14. Patterns of drug use and the influence of gender on self-reports of memory ability in ecstasy users: a web-based study.
    Rodgers J, Buchanan T, Scholey AB, Heffernan TM, Ling J, Parrott AC.
    J Psychopharmacol; 2003 Dec; 17(4):389-96. PubMed ID: 14870950
    [Abstract] [Full Text] [Related]

  • 15. Depression, impulsiveness, sleep, and memory in past and present polydrug users of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy).
    Taurah L, Chandler C, Sanders G.
    Psychopharmacology (Berl); 2014 Feb; 231(4):737-51. PubMed ID: 24114426
    [Abstract] [Full Text] [Related]

  • 16. Prospective memory functioning among ecstasy/polydrug users: evidence from the Cambridge Prospective Memory Test (CAMPROMPT).
    Hadjiefthyvoulou F, Fisk JE, Montgomery C, Bridges N.
    Psychopharmacology (Berl); 2011 Jun; 215(4):761-74. PubMed ID: 21301817
    [Abstract] [Full Text] [Related]

  • 17. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users.
    Thomasius R, Petersen K, Buchert R, Andresen B, Zapletalova P, Wartberg L, Nebeling B, Schmoldt A.
    Psychopharmacology (Berl); 2003 Apr; 167(1):85-96. PubMed ID: 12632248
    [Abstract] [Full Text] [Related]

  • 18. Ecstasy (MDMA) does not have long-term effects on aggressive interpretative bias: a study comparing current and ex-ecstasy users with polydrug and drug-naive controls.
    Hoshi R, Cohen L, Lemanski L, Piccini P, Bond A, Curran HV.
    Exp Clin Psychopharmacol; 2007 Aug; 15(4):351-8. PubMed ID: 17696682
    [Abstract] [Full Text] [Related]

  • 19. Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs.
    Halpern JH, Sherwood AR, Hudson JI, Gruber S, Kozin D, Pope HG.
    Addiction; 2011 Apr; 106(4):777-86. PubMed ID: 21205042
    [Abstract] [Full Text] [Related]

  • 20. Everyday and prospective memory deficits in ecstasy/polydrug users.
    Hadjiefthyvoulou F, Fisk JE, Montgomery C, Bridges N.
    J Psychopharmacol; 2011 Apr; 25(4):453-64. PubMed ID: 20123936
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.